Article
[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].
Revue des maladies respiratoires - 1 May 2017
Caliez J, Monnet I, Pujals A, Rousseau-Bussac G, Jabot L, Boudjemaa A, Leroy K, Chouaid C
Abstract excerpt
INTRODUCTION: Among patients with non-small-cell lung cancer, coexistence of EGFR mutation and ALK rearrangement is rare. We describe the clinical features of two patients with this double anomaly. CASE REPORTS: A 62-year-old Caucasian non-smoking woman was diagnosed with cT4N0M0 lung adenocarcin...
Topics
- Adenocarcinoma
- Adenocarcinoma of Lung
- Anaplastic Lymphoma Kinase
- Antineoplastic Combined Chemotherapy Protocols
- Cisplatin
- Crizotinib
- ErbB Receptors
- Erlotinib Hydrochloride
- Female
- Humans
- Lung Neoplasms
- Middle Aged
